Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Co-expression in tissue-specific gene networks links genes in cancer-susceptibility loci to known somatic driver genes

View ORCID ProfileCarlos G. Urzúa-Traslaviña, View ORCID ProfileTijs van Lieshout, View ORCID ProfileFloranne Boulogne, View ORCID ProfileKevin Domanegg, Mahmoud Zidan, View ORCID ProfileOlivier B. Bakker, View ORCID ProfileAnnique Claringbould, View ORCID ProfileJeroen de Ridder, View ORCID ProfileWilbert Zwart, View ORCID ProfileHarm-Jan Westra, View ORCID ProfilePatrick Deelen, View ORCID ProfileLude Franke
doi: https://doi.org/10.1101/2023.09.08.23295254
Carlos G. Urzúa-Traslaviña
1University Medical Center Groningen, Department of Genetics, Groningen, Netherlands
2Oncode Institute, Utrecht, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Carlos G. Urzúa-Traslaviña
Tijs van Lieshout
1University Medical Center Groningen, Department of Genetics, Groningen, Netherlands
2Oncode Institute, Utrecht, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tijs van Lieshout
Floranne Boulogne
1University Medical Center Groningen, Department of Genetics, Groningen, Netherlands
2Oncode Institute, Utrecht, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Floranne Boulogne
Kevin Domanegg
1University Medical Center Groningen, Department of Genetics, Groningen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kevin Domanegg
Mahmoud Zidan
1University Medical Center Groningen, Department of Genetics, Groningen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier B. Bakker
3Wellcome Sanger Institute, Human Genetics, Hinxton, United Kingdom
4Open Targets, Hinxton, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Olivier B. Bakker
Annique Claringbould
1University Medical Center Groningen, Department of Genetics, Groningen, Netherlands
5EMBL Heidelberg, Structural and Computational Biology Unit, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Annique Claringbould
Jeroen de Ridder
2Oncode Institute, Utrecht, Netherlands
6University Medical Center Utrecht, Utrecht, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jeroen de Ridder
Wilbert Zwart
2Oncode Institute, Utrecht, Netherlands
7Netherlands Cancer Institute, Division of Oncogenomics, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wilbert Zwart
Harm-Jan Westra
1University Medical Center Groningen, Department of Genetics, Groningen, Netherlands
2Oncode Institute, Utrecht, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Harm-Jan Westra
Patrick Deelen
1University Medical Center Groningen, Department of Genetics, Groningen, Netherlands
2Oncode Institute, Utrecht, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Patrick Deelen
Lude Franke
1University Medical Center Groningen, Department of Genetics, Groningen, Netherlands
2Oncode Institute, Utrecht, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lude Franke
  • For correspondence: l.h.franke{at}umcg.nl
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The genetic background of cancer remains complex and challenging to integrate. Many somatic mutations in genes are known to cause and drive cancer, while genome-wide association studies (GWAS) of cancer have revealed many germline risk factors associated with cancer. However, the overlap between known somatic driver genes and positional candidate genes from GWAS loci is surprisingly small. We hypothesised that genes from multiple independent cancer GWAS loci should show tissue-specific co-regulation patterns that converge on cancer-specific driver genes.

Results We studied recent well powered GWAS of breast, prostate, colorectal and skin cancer by estimating co-expression between genes and subsequently prioritising genes that show co- expression with genes mapping within susceptibility loci from cancer GWAS. We observed that the prioritised genes were strongly enriched for cancer drivers defined by COSMIC, intOGen and Dietlein et al. The enrichment of known cancer driver genes was most significant when using co-expression networks derived from non-cancer samples from the relevant tissue of origin.

Conclusion We show how genes in risk loci identified by cancer GWAS can be linked to known cancer driver genes through tissue-specific co-expression networks. This provides an important explanation for why seemingly unrelated sets of genes that harbour either germline risk factors or somatic mutations can eventually cause the same type of disease.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

P.D. is supported by a Dutch Research Council (NWO) ZonMW-VENI grant (no. 9150161910057). L.F. is supported by a grant from the NWO (ZonMW-VICI 09150182010019 to L.F.), a European Research Council Starting Grant (grant agreement 637640 (ImmRisk)), and through a Senior Investigator Grant from the Oncode Institute and a grant from Saxum Volutum (Pericode).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The GWAS summary statistics are made available in the GWAS catalogue (https://www.ebi.ac.uk/gwas/) and BCAC (https://bcac.ccge.medschl.cam.ac.uk/). The data on the Cancer drivers is available under the website of intOGen (https://www.intogen.org/download), Zenodo of Dietlein et al. (https://zenodo.org/record/5913867) and the website of COSMIC (https://cancer.sanger.ac.uk/cosmic). RNA-seq samples can be retrieved from recount3 (http://rna.recount.bio/).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present work are contained in the manuscript with the exception of the generated tissue-specific networks that are available upon reasonable request to the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 08, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Co-expression in tissue-specific gene networks links genes in cancer-susceptibility loci to known somatic driver genes
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Co-expression in tissue-specific gene networks links genes in cancer-susceptibility loci to known somatic driver genes
Carlos G. Urzúa-Traslaviña, Tijs van Lieshout, Floranne Boulogne, Kevin Domanegg, Mahmoud Zidan, Olivier B. Bakker, Annique Claringbould, Jeroen de Ridder, Wilbert Zwart, Harm-Jan Westra, Patrick Deelen, Lude Franke
medRxiv 2023.09.08.23295254; doi: https://doi.org/10.1101/2023.09.08.23295254
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Co-expression in tissue-specific gene networks links genes in cancer-susceptibility loci to known somatic driver genes
Carlos G. Urzúa-Traslaviña, Tijs van Lieshout, Floranne Boulogne, Kevin Domanegg, Mahmoud Zidan, Olivier B. Bakker, Annique Claringbould, Jeroen de Ridder, Wilbert Zwart, Harm-Jan Westra, Patrick Deelen, Lude Franke
medRxiv 2023.09.08.23295254; doi: https://doi.org/10.1101/2023.09.08.23295254

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Genetic and Genomic Medicine
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)